MarketsSingle-sourceDeveloping
2.1
Guard Therapeutics secures conditional Nasdaq First North listing for reverse acquisition
Dagens IndustriLO·SE·1 day ago
Bio-Works has booked a new order valued at 22.6 million SEK from an existing customer. The announcement confirms continued demand from the client base, though the impact on overall annual revenue remains subject to delivery timelines.